Cargando…
Natural products as starting points for future anti-malarial therapies: going back to our roots?
BACKGROUND: The discovery and development of new anti-malarials are at a crossroads. Fixed dose artemisinin combination therapy is now being used to treat a hundred million children each year, with a cost as low as 30 cents per child, with cure rates of over 95%. However, as with all anti-infective...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059461/ https://www.ncbi.nlm.nih.gov/pubmed/21411014 http://dx.doi.org/10.1186/1475-2875-10-S1-S3 |